Prudential Financial
KURA icon

Prudential Financial’s Kura Oncology KURA Stock Holding History

Prudential Financial’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$336K Sell
41,280
-50,920
-55% -$437K ﹤0.01% 1988
2025
Q4 		$958K Buy
92,200
+8,452
+10% +$88.7K ﹤0.01% 1610
2025
Q3 		$741K Buy
+83,748
New +$597K ﹤0.01% 1773
2024
Q3 		– Sell
-18,277
Closed -$376K – 2758
2024
Q2 		$376K Buy
18,277
+940
+5% +$19.3K ﹤0.01% 2290
2024
Q1 		$370K Buy
+17,337
New +$337K ﹤0.01% 2274
2021
Q1 		– Sell
-6,627
Closed -$216K – 2515
2020
Q4 		$216K Buy
+6,627
New +$233K ﹤0.01% 2341
2020
Q2 		– Sell
-17,694
Closed -$176K – 2436
2020
Q1 		$176K Sell
17,694
-49,399
-74% -$565K ﹤0.01% 2203
2019
Q4 		$923K Buy
67,093
+471
+0.7% +$6.98K ﹤0.01% 1886
2019
Q3 		$1.01M Buy
+66,622
New +$1.19M ﹤0.01% 1850

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Prudential Financial's KURA Position: Q1 2026 in Review

Prudential Financial reduced its Kura Oncology (KURA) stake by 55% in Q1 2026, selling an estimated $437K and leaving 41,280 shares worth $336K. The position accounts for ﹤0.01% of the portfolio, ranked #1988.

Prudential Financial first reported a position in KURA in Q3 2019 and has held it in 9 quarters since. The position peaked at $1.01M in Q3 2019. 220 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

  • Prudential Financial held 41,280 shares of Kura Oncology worth $336K as of Q1 2026.
  • Prudential Financial sold 50,920 Kura Oncology shares in Q1 2026, an estimated $437K.
  • Kura Oncology made up ﹤0.01% of Prudential Financial's portfolio in Q1 2026, its #1988 holding.
  • Prudential Financial first reported a position in Kura Oncology in Q3 2019 and has held it in 9 quarters since.
  • Prudential Financial's Kura Oncology position peaked at $1.01M in Q3 2019.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.